Skip to main content
logo
Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.9775
-0.0475 (-4.63%)
Jul 28, 2026, 3:14 PM EDT - Market open

Bone Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2332218
Market Cap Growth
-63.80%-6.27%15.01%50.36%-91.19%-
Enterprise Value
-2.59-2.73-0.55-0.61-5.9311.56
Last Close Price
0.981.455.6427.12151.142536.92

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.390.480.800.830.272.77
P/TBV Ratio
0.310.320.410.41--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
-0.840.130.061.62-
EV/EBIT Ratio
-0.840.130.061.62-
EV/FCF Ratio
-1.010.130.061.66-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.97-0.99-0.95-1.04-1.27-1.01
Net Debt / EBITDA Ratio
1.511.650.790.322.066.06
Net Debt / FCF Ratio
1.761.980.810.322.115.43
Quick Ratio
14.6712.778.803.642.9666.81
Current Ratio
16.0913.8510.224.503.3366.81
Return on Equity (ROE)
-56.89%-70.17%-128.71%-202.15%-23.71%45.26%
Return on Assets (ROA)
-55.71%-66.99%-111.04%-154.15%-48.32%-32.97%
Return on Invested Capital (ROIC)
-3278.46%-3206.85%-22021.82%---
Return on Capital Employed (ROCE)
-59.75%-73.01%-132.05%-212.98%-58.54%30.95%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-316.40%-364.45%-476.79%---
Total Shareholder Return
-316.40%-364.45%-476.79%---
SEC Filings: 10-K · 10-Q